Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics

• Váldodahkkit: Anna D. Louie (Dahkki), Kelsey Huntington (Dahkki), Lindsey Carlsen (Dahkki), Lanlan Zhou (Dahkki), Wafik S. El-Deiry (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2021-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Biomarkers can contribute to clinical cancer therapeutics at multiple points along the patient's diagnostic and treatment course. Diagnostic biomarkers can screen or classify patients, while prognostic biomarkers predict their survival. Biomarkers can also predict treatment efficacy or toxicity...